Literature DB >> 6323317

Pneumocystis carinii: oxygen uptake, antioxidant enzymes, and susceptibility to oxygen-mediated damage.

E L Pesanti.   

Abstract

The ability of Pneumocystis carinii obtained by alveolar lavage of rats with glucocorticoid-induced pneumocystosis to utilize molecular oxygen, the concentrations of selected antioxidant enzymes, and the susceptibility of P. carinii to in vitro killing by oxygen radical-generating systems have been evaluated. As expected of an organism which has been found to convert radiolabeled glucose to CO2, the parasite utilizes molecular oxygen. No evidence for pathways of oxygen utilization other than the cytochrome pathway was found; cyanide virtually abolished oxygen consumption. Although readily detectable levels of the antioxidant enzymes superoxide dismutase, catalase, and glutathione peroxidase were present in the P. carinii preparations, only superoxide dismutase was present at levels that suggested that the activity was indeed a property of the parasite. Almost certainly, P. carinii does not possess effective concentrations of catalase. In addition, it was found that P. carinii is susceptible to the lethal actions of hydrogen peroxide and superoxide, but the parasite seems to be resistant to the effects of a hydroxyl radical-generating system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323317      PMCID: PMC263450          DOI: 10.1128/iai.44.1.7-11.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Polymorphonuclear leukocyte species differences in the disposal of hydrogen peroxide (H2O2).

Authors:  C P Higgins; R L Baehner; J McCallister; L A Boxer
Journal:  Proc Soc Exp Biol Med       Date:  1978-07

2.  Uptake and degradation of Pneumocystis carinii by macrophages in vitro.

Authors:  L A Von Behren; E L Pesanti
Journal:  Am Rev Respir Dis       Date:  1978-12

3.  Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features.

Authors:  P D Walzer; D P Perl; D J Krogstad; P G Rawson; M G Schultz
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

4.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

5.  Nude mouse: a new experimental model for Pneumocystis carinii infection.

Authors:  P D Walzer; V Schnelle; D Armstrong; P P Rosen
Journal:  Science       Date:  1977-07-08       Impact factor: 47.728

6.  Mediation of immunity to intracellular infection (Toxoplasma and Besnoitia) within somatic cells.

Authors:  M Chinchilla; J K Frenkel
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

7.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

Authors:  D E Paglia; W N Valentine
Journal:  J Lab Clin Med       Date:  1967-07

8.  Catalase, superoxide dismutase, and virulence of Staphylococcus aureus. In vitro and in vivo studies with emphasis on staphylococcal--leukocyte interaction.

Authors:  G L Mandell
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

9.  Pneumocystis carinii pneumonia: epidemiology in Japan, and cyst concentration method.

Authors:  Y Yoshida; T Ikai
Journal:  Zentralbl Bakteriol Orig A       Date:  1979-07

10.  Bactericidal activity of a superoxide anion-generating system. A model for the polymorphonuclear leukocyte.

Authors:  H Rosen; S J Klebanoff
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more
  8 in total

1.  Pneumocystis carinii induces an oxidative burst in alveolar macrophages.

Authors:  H A Hidalgo; R J Helmke; V F German; J A Mangos
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina.

Authors:  Michael P Nelson; Benjamin S Christmann; Jessica L Werner; Allison E Metz; Jennifer L Trevor; Clifford A Lowell; Chad Steele
Journal:  J Immunol       Date:  2011-01-10       Impact factor: 5.422

3.  Histoenzymological study of selected dehydrogenase enzymes in Pneumocystis carinii.

Authors:  M A Mazer; J A Kovacs; J C Swan; J E Parrillo; H Masur
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

4.  Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; C K Kim; J Foy; M J Linke; M T Cushion
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

5.  Use of an ATP bioluminescent assay to evaluate viability of Pneumocystis carinii from rats.

Authors:  F Chen; M T Cushion
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

6.  Phospholipid profile of Pneumocystis carinii and its interaction with alveolar type II epithelial cells.

Authors:  E L Pesanti
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

7.  Rapid separation of Pneumocystis carinii from lung lavage fluids.

Authors:  E L Pesanti; B A McCarron
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

8.  Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor.

Authors:  Chad Steele; Luis Marrero; Steve Swain; Allen G Harmsen; Mingquan Zheng; Gordon D Brown; Siamon Gordon; Judd E Shellito; Jay K Kolls
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.